PMC’s 17th Annual Personalized Medicine
With confirmed speakers from every sector of the health care system and media participation from representatives of outlets including The Washington Post, Fortune magazine, and Endpoints News, the 17th Annual Personalized Medicine Conference provided business executives, researchers, and patients with an opportunity to demonstrate how far personalized medicine has come — and how far it still has to go — two decades after the first sequencing of a human genome in 2003.
With confirmed speakers from every sector of the health care system and media participation from representatives of outlets including The Washington Post, Fortune magazine, and Endpoints News, the 17th Annual Personalized Medicine Conference provided business executives, researchers, and patients with an opportunity to demonstrate how far personalized medicine has come — and how far it still has to go — two decades after the first sequencing of a human genome in 2003.
With confirmed speakers from every sector of the health care system and media participation from representatives of outlets including The Washington Post, Fortune magazine, and Endpoints News, the 17th Annual Personalized Medicine Conference provided business executives, researchers, and patients with an opportunity to demonstrate how far personalized medicine has come — and how far it still has to go — two decades after the first sequencing of a human genome in 2003.
With confirmed speakers from every sector of the health care system and media participation from representatives of outlets including The Washington Post, Fortune magazine, and Endpoints News, the 17th Annual Personalized Medicine Conference provided business executives, researchers, and patients with an opportunity to demonstrate how far personalized medicine has come — and how far it still has to go — two decades after the first sequencing of a human genome in 2003.
With confirmed speakers from every sector of the health care system and media participation from representatives of outlets including The Washington Post, Fortune magazine, and Endpoints News, the 17th Annual Personalized Medicine Conference provided business executives, researchers, and patients with an opportunity to demonstrate how far personalized medicine has come — and how far it still has to go — two decades after the first sequencing of a human genome in 2003.
With confirmed speakers from every sector of the health care system and media participation from representatives of outlets including The Washington Post, Fortune magazine, and Endpoints News, the 17th Annual Personalized Medicine Conference provided business executives, researchers, and patients with an opportunity to demonstrate how far personalized medicine has come — and how far it still has to go — two decades after the first sequencing of a human genome in 2003.
During this keynote interview with former Fortune editor-in-chief Clifton Leaf, Labcorp Chief Medical & Scientific Officer Dr. Brian Caveney shares his perspective on the future of personalized medicine and the diagnostics industry.